Home » Stocks » EMIS

Emisphere Technologies, Inc. (EMIS)

Stock Price: $6.92 USD -0.14 (-1.98%)
Updated Oct 30, 2020 10:40 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 421.10M
Revenue (ttm) 1.04M
Net Income (ttm) -2.15M
Shares Out 60.85M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $6.92
Previous Close $7.06
Change ($) -0.14
Change (%) -1.98%
Day's Open 6.80
Day's Range 6.80 - 6.94
Day's Volume 1,393
52-Week Range 3.88 - 9.16

More Stats

Market Cap 421.10M
Enterprise Value 484.55M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 60.85M
Float 60.85M
EPS (basic) -0.04
EPS (diluted) -0.10
FCF / Share -0.09
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 522,334
Short Ratio 1.65
Short % of Float 0.86%
Beta 1.36
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 403.35
PB Ratio n/a
Revenue 1.04M
Operating Income -6.22M
Net Income -2.15M
Free Cash Flow -5.72M
Net Cash -63.45M
Net Cash / Share -1.04
Gross Margin -29.21%
Operating Margin -595.59%
Profit Margin -205.70%
FCF Margin -547.99%
ROA -43.27%
ROE n/a
ROIC 18.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $6.92
Target: 3.25
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth190.75%-----8.7%-63.35%-93.84%-
Gross Profit-0.31-0.48----
Operating Income-7.84-18.10-9.31-7.60-6.82-8.14-11.54-14.55-26.32-20.65
Net Income-10.04-40.38-25.38-20.94-1.9315.05-56.91-16.82-24.39-16.93
Shares Outstanding60.6960.6960.6960.6960.6956.2946.2134.6830.3429.04
Earnings Per Share-0.17-0.67-0.42-0.35-0.030.25-1.23-0.49-0.80-0.76
Operating Cash Flow-6.81-2.79-8.372.87-3.00-9.69-4.89-11.93-6.68-14.40
Capital Expenditures----0.050.01--0.990.03-0.27
Free Cash Flow-6.81-2.79-8.372.82-2.99-9.69-4.89-10.94-6.66-14.67
Cash & Equivalents6.0912.903.684.051.733.325.593.837.4714.10
Total Debt67.5961.1744.5533.0833.6126.0220.3912.6830.2215.84
Net Cash / Debt-61.50-48.27-40.86-29.03-31.88-22.70-14.80-8.86-22.75-1.74
Book Value-161-152-112-86.80-66.07-64.53-82.52-35.23-37.03-13.67
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Emisphere Technologies, Inc.
Country United States
Employees 6

Stock Information

Ticker Symbol EMIS
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: EMIS


Emisphere Technologies operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.